UNSPSC 51151609: Propantheline
Commodity
Code facts
- Part of
-
-
51000000
-
51150000
- 51151600
-
51150000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51151609
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes an antimuscarinic agent with the molecular formula C23H30NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1306V2B0Q8, chemically known as 2-propanaminium, n-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)- but generally known as propantheline, which bears US NIH Compound Identifier 4934. European Medicines Agency schedules Propantheline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04081MIG.
Read the full definition
World Health Organization schedules propantheline in its Anatomical Therapeutic Chemical (ATC) Classification. PROPANTHELINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PROPANTHELINE remains the US FDA Preferred Term for this commodity. Propantheline bears US NLM identifiers UMLS ID C0033447 and NCI Concept Code C78077. SMILES: O(CC[N](C(C)C)(C(C)C)C)C(=O)C1C2C(OC3C1CCCC3)CCCC2.
About UNSPSC 51151609
UNSPSC 51151609 Propantheline is a Commodity code that does not align with the recent state and local activity recorded under it. The single recent solicitation tagged to this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—involves pharmaceutical products and medical equipment procurement, not propantheline (an anticholinergic medication used to treat gastrointestinal conditions). The mismatch suggests either a classification error in the source data or a temporary administrative miscoding. The scope of work under the code's nominal definition would cover propantheline tablets or solutions for state and local health agencies, correctional facilities, or institutional healthcare programs, but no such solicitations appear in the recent record.
Seminole County's naloxone and drug deactivation systems procurement, posted June 30, 2026 with a response deadline of July 26, 2023 (dates that conflict within the source), represents the only available recent opportunity. The county issued an IFB seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires vendors to submit bids electronically, include all shipping and delivery costs in proposals, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with an optional one-year renewal and includes a three-month probationary termination window. The solicitation notes potential FEMA funding, which introduces federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations appear in the opportunity. This code shows little relevant recent activity aligned with its propantheline definition.
Quick answers
What is UNSPSC 51151609?
UNSPSC 51151609 is Propantheline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51151609?
UNSPSC 51151609 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51151609
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code